American depositary receipt

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Banco Santander, S.A. Investors to Inquire About Securities Class Action Investigation - SAN

Retrieved on: 
Dimanche, avril 7, 2024

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22671 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, A LEADING LAW FIRM, Encourages Li Auto Inc. Investors to Inquire About Securities Class Action Investigation - LI

Retrieved on: 
Mercredi, avril 3, 2024

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=11199 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=11199 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Banco Santander, S.A. Investors to Inquire About Securities Class Action Investigation - SAN

Retrieved on: 
Mercredi, mars 27, 2024

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22671 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

EVVTY DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Evolution AB (publ) Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EVVTY

Retrieved on: 
Dimanche, mars 24, 2024

WHAT TO DO NEXT: To join the Evolution class action, go to https://rosenlegal.com/submit-form/?case_id=22119 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Evolution class action, go to https://rosenlegal.com/submit-form/?case_id=22119 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2024.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

JBSAY LOSS ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages JBS S.A. Investors to Inquire About Securities Class Action Investigation - JBSAY

Retrieved on: 
Samedi, mars 23, 2024

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22976 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22976 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages JBS S.A. Investors to Inquire About Securities Class Action Investigation - JBSAY

Retrieved on: 
Dimanche, mars 17, 2024

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22976 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

EVVTY DEADLINE NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Evolution AB (publ) Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EVVTY

Retrieved on: 
Vendredi, mars 15, 2024

WHAT TO DO NEXT: To join the Evolution class action, go to https://rosenlegal.com/submit-form/?case_id=22119 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Evolution class action, go to https://rosenlegal.com/submit-form/?case_id=22119 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2024.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Grabar Law Office Investigates Claims on Behalf of Shareholders of JBS S.A. (JBSAY)

Retrieved on: 
Vendredi, mars 15, 2024

It is alleged that JBS USA continued to make these false claims despite receiving a warning from BBB National Programs' National Advertising Division (NAD), which determined that the company's evidence did not support the net zero claims it was making to consumers.

Key Points: 
  • It is alleged that JBS USA continued to make these false claims despite receiving a warning from BBB National Programs' National Advertising Division (NAD), which determined that the company's evidence did not support the net zero claims it was making to consumers.
  • The NAD recommended that JBS USA stop making these net zero claims in its advertising.
  • This recommendation was affirmed by the National Advertising Review Board.
  • If you are a JBS SA investor and would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/jbs-shareholder-investigation/ , contact Joshua H. Grabar at [email protected] or Mia R. Heller at [email protected] , or call 267-507-6085.

Jianzhi Education Technology Group Company Limited Reports Fiscal Year 2023 Financial Results

Retrieved on: 
Mardi, avril 9, 2024

The Company’s gross profit margin improved to 3.7% for the year ended December 31, 2023 from negative 1.1% for the year ended December 31, 2022.

Key Points: 
  • The Company’s gross profit margin improved to 3.7% for the year ended December 31, 2023 from negative 1.1% for the year ended December 31, 2022.
  • Sales and Marketing Expenses: The sales and marketing expenses was RMB7.6 million (US$1.1 million) and RMB7.1 million for the fiscal years 2023 and 2022, respectively.
  • General and Administrative Expenses: The general and administrative expenses decreased to RMB22.2 million (US$3.1 million) for the fiscal year 2023 from RMB53.2 million for the fiscal year 2022.
  • Accordingly, the Company charged impairment of RMB155.3 million (US$21.9 million) against long-term prepayments for the year ended December 31, 2023.

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

Retrieved on: 
Jeudi, avril 4, 2024

DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2023 and fiscal year 2023 and key business updates.

Key Points: 
  • DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2023 and fiscal year 2023 and key business updates.
  • We expect to have fully executed this change by the end of 2024 and expect this will deliver significant annualised savings.
  • The assets and liabilities attributable to Fitzgerald Industries have been removed from our Consolidated Balance Sheet as of December 31, 2023.
  • Total revenues for Q4, 2023 were $13.4m which compares to $15.7m in Q4, 2022, a decrease of 14.6% and which were broken down as follows: